Figure 4From: Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS studyPercentage of patients to 1998 and 2003 European LDL-C goals [7,9] at 4 weeks. *p < 0.001 vs atorvastatin LDL-C: Low-density lipoprotein cholesterolBack to article page